Alaunos Therapeutics Inc. – Filings and Transcripts

NASDAQ: TCRT
Share price (7/9/26): $2.07
Market cap (7/9/26): $50.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus unintentially filed late

Shelf registration – amended

Initial registration of new securities

Shelf registration – amended

Ownership Filter

Postma Robert W

News Filter

Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study

Reports Broad Metabolic Improvements With ALN1003 in Obese Mouse Studies

Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Announces Positive Preclinical Proof-Of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission